Quarterly report pursuant to Section 13 or 15(d)

Segment Information

v3.21.1
Segment Information
 3 Months Ended
Apr. 03, 2021
Segment Reporting [Abstract]  
Segment Information

Note 20: Segment Information

We operate within targeted markets through three reportable segments for continuing operations: biotechnology, recycling, and technology. The biotechnology segment commenced operations in September 2019 and is focused on development of new and innovative solutions for ending the opioid epidemic ranging from digital technologies to educational advocacy. The recycling segment includes all fees charged and costs incurred for collecting, recycling and installing appliances for utilities and other customers. The recycling segment also includes byproduct revenue, which is primarily generated through the recycling of appliances. The nature of products, services and customers for both segments varies significantly. As such, the segments are managed separately. Our Chief Executive Officer has been identified as the Chief Operating Decision Maker (“CODM”). The CODM evaluates performance and allocates resources based on sales and income from operations of each segment. Operating loss represents revenues less cost of revenues and operating expenses, including certain allocated selling, general and administrative costs. There are no intersegment sales or transfers.

 

The following tables present our segment information for the 13 weeks ended April 3, 2021 and March 28, 2020:

 

 

Thirteen Weeks Ended

 

 

April 3, 2021

 

 

March 28, 2020

 

Revenues

 

 

 

 

 

 

 

Biotechnology

$

—

 

 

$

—

 

Recycling

 

8,672

 

 

 

8,450

 

Technology

 

—

 

 

 

—

 

Total Revenues

$

8,672

 

 

$

8,450

 

Gross profit

 

 

 

 

 

 

 

Biotechnology

$

—

 

 

$

—

 

Recycling

 

1,421

 

 

 

1,474

 

Technology

 

—

 

 

 

—

 

Total Gross profit

$

1,421

 

 

$

1,474

 

Operating loss

 

 

 

 

 

 

 

Biotechnology

$

(242

)

 

$

(343

)

Recycling

 

(928

)

 

 

(1,929

)

Technology

 

(939

)

 

 

(1,127

)

Total Operating loss

$

(2,109

)

 

$

(3,399

)

Depreciation and amortization

 

 

 

 

 

 

 

Biotechnology

$

—

 

 

$

—

 

Recycling

 

108

 

 

 

80

 

Technology

 

937

 

 

 

937

 

Total Depreciation and amortization

$

1,045

 

 

$

1,017

 

Interest (income) expense, net

 

 

 

 

 

 

 

Biotechnology

$

—

 

 

$

—

 

Recycling

 

73

 

 

 

113

 

Technology

 

—

 

 

 

—

 

Total Interest expense, net

$

73

 

 

$

113

 

Net income (loss) before benefit from income taxes

 

 

 

 

 

 

 

Biotechnology

$

(242

)

 

$

(343

)

Recycling

 

1,639

 

 

 

(1,231

)

Technology

 

(897

)

 

 

(1,120

)

Total Net income (loss) before benefit from income taxes

$

500

 

 

$

(2,694

)

 

 

 

As of

April 3,

2021

 

 

As of

January 2,

2021

 

Assets

 

 

 

 

 

 

 

 

Biotechnology

 

$

—

 

 

$

—

 

Recycling

 

 

14,289

 

 

 

10,614

 

Technology

 

 

13,016

 

 

 

13,737

 

Total Assets

 

$

27,305

 

 

$

24,351

 

 

 

 

 

 

 

 

 

 

Intangible assets

 

 

 

 

 

 

 

 

Biotechnology

 

$

—

 

 

$

—

 

Recycling

 

 

446

 

 

 

470

 

Technology

 

 

12,585

 

 

 

13,519

 

Total Intangible assets

 

$

13,031

 

 

$

13,989